findmyKOL
Clinical trialNCT05753722RecruitingPhase 1Interventional

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

SponsorIncendia TherapeuticsEnrollment270Advanced or Metastatic Solid TumorsNSCLCNon Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Honor Health Research Institute

    Scottsdale, Arizona, United States

    Frank Yung-Chin Tsai, MD
    Recruiting
  • Yale Cancer Center

    New Haven, Connecticut, United States

    Patricia LoRusso, DO
    Recruiting
  • Mass General Cancer Center

    Boston, Massachusetts, United States

    Aparna Parikh, MD
    Recruiting
  • Providence Cancer Institute Franz Clinic

    Portland, Oregon, United States

    Rachel Sanborn, MD
    Recruiting
  • University of Pittsburgh Medical Center Hillman Cancer Center

    Pittsburgh, Pennsylvania, United States

    Completed
  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, United States

    Jordan Berlin, MD
    Recruiting
  • Next Houston

    Houston, Texas, United States

    Jennifer Segar, MD
    Recruiting
  • the University of Texas Md Anderson Cancer Center

    Houston, Texas, United States

    Funda Meric-Bernstam, MD
    Recruiting
  • Next Oncology

    Irving, Texas, United States

    Shiraj Sen, MD, PhD
    Recruiting
  • Next Oncology

    San Antonio, Texas, United States

    David Sommerhalder, MD
    Recruiting
  • Next Oncology

    Fairfax, Virginia, United States

    Alex Spira, MD,PhD,FACP
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Mar 2023
Primary completion
30 Sept 2027
Completion
30 Sept 2027
Last update posted
23 Feb 2026
Registered enrollment
270
Registry id
NCT05753722
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.